Skip to main content
ALYFTREK 125 mg/1, 50 mg/1, 10 mg/1 tablet, film coated by Vertex Pharmaceuticals Incorporated
ALYFTREK, 125 mg/1, 50 mg/1, 10 mg/1, tablet, film coated Drug class: Cystic Fibrosis Transmembrane Conductance Regulator Potentiator. Available on prescription only. Listed by Vertex Pharmaceuticals Incorporated.
Prescription only

ALYFTREK

vanzacaftor, tezacaftor, and deutivacaftor

Listed by Vertex Pharmaceuticals Incorporated

Strength
125 mg/1, 50 mg/1, 10 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Cystic Fibrosis Transmembrane Conductance Reg…

What it contains

  • Vanzacaftor 125 mg/1
  • Tezacaftor 50 mg/1
  • Deutivacaftor 10 mg/1

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
Approval route NDA — original brand approval
NDC code 51167-121
FDA application NDA218730
RxNorm concept 2701438
Package sizes listed 1
Marketed since December 2024

Other products containing Vanzacaftor

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

ALYFTREK

vanzacaftor, tezacaftor, and deutivacaftor

Strength
50 mg/1, 20 mg/1, 4 mg/1
Form
Tablet, Film Coated
Class
Cystic Fibrosis Transmembrane Conductan…
Rx only

Vertex Pharmaceuticals Incorporated

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.